首页> 美国卫生研究院文献>The Journal of Veterinary Medical Science >Inhibition of growth of canine-derived vascular endothelial cells by non-steroidal anti-inflammatory drugs and atrial natriuretic peptide
【2h】

Inhibition of growth of canine-derived vascular endothelial cells by non-steroidal anti-inflammatory drugs and atrial natriuretic peptide

机译:非甾体抗炎药和心钠素抑制犬源性血管内皮细胞生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study investigated the direct effects of non-steroidal anti-inflammatory drugs (NSAIDs) and atrial natriuretic peptide (ANP) on canine-derived vascular endothelial cells (VECs). VECs were isolated and cultured from canine arteries and veins. The mRNA expressions of vascular endothelial growth factor receptor 2, cyclooxygenase-2, and natriuretic peptide receptor 1 were detected in the cultured VECs. The viability of the cultured VECs was reduced in a dose-dependent manner by meloxicam, carprofen, and robenacoxib. By contrast, dose escalations of ANP had only marginal influence on the viability of cultured VECs. NSAIDs may potentially serve as not only analgesic agents against cancerous and perioperative pain but also as adjuvant anti-angiogenic drugs in dogs with malignant tumors.
机译:这项研究调查了非甾体类抗炎药(NSAID)和心钠素(ANP)对犬源性血管内皮细胞(VEC)的直接作用。从犬的动脉和静脉中分离并培养VEC。在培养的VECs中检测到血管内皮生长因子受体2,环氧合酶-2和利钠肽受体1的mRNA表达。美洛昔康,卡洛芬和罗贝纳昔以剂量依赖性方式降低了培养的VEC的活力。相比之下,ANP的剂量递增仅对培养的VEC的生存能力产生很小的影响。 NSAIDs不仅可能作为抗癌和围手术期疼痛的止痛药,而且还可以作为恶性肿瘤犬的辅助抗血管生成药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号